COR 📈 Cencora - Overview

Cencora, Inc. operates as a global healthcare company, sourcing and distributing pharmaceutical products to a wide range of customers in the United States and internationally. The company's U.S. Healthcare Solutions segment is a critical component of its business, providing a broad array of products and services to various healthcare providers, including acute care hospitals, health systems, retail pharmacies, and medical clinics. These products encompass pharmaceuticals, over-the-counter healthcare items, home healthcare supplies, and equipment, as well as related services such as pharmacy management, staffing, and consulting. Additionally, this segment offers supply management software, packaging solutions, and clinical trial support services, further solidifying its position as a comprehensive healthcare solutions provider.

The U.S. Healthcare Solutions segment also caters to the companion animal and production animal markets, distributing pharmaceuticals, vaccines, and other products. Moreover, it provides sales force services to manufacturers, enabling them to effectively reach their target markets. The segment's services extend to specialty products, including plasma and other blood products, injectable pharmaceuticals, and vaccines, which are critical for various disease states, such as oncology. By offering these specialized services, Cencora, Inc. supports healthcare providers in delivering high-quality patient care.

Cencora, Inc.'s International Healthcare Solutions segment plays a vital role in the company's global operations, providing international pharmaceutical wholesale and related services, as well as global commercialization services. This segment distributes pharmaceuticals and other healthcare products to pharmacies, doctors, health centers, and hospitals worldwide. Furthermore, it offers specialty transportation and logistics services tailored to the biopharmaceutical industry, ensuring the safe and efficient delivery of temperature-sensitive and high-value products. With its extensive network and expertise, Cencora, Inc. is well-positioned to navigate the complexities of global healthcare markets.

With a rich history dating back to 1871, Cencora, Inc. has evolved significantly over the years, adapting to changes in the healthcare landscape. Formerly known as AmerisourceBergen Corporation, the company changed its name to Cencora, Inc. in August 2023, marking a new chapter in its history. Headquartered in Conshohocken, Pennsylvania, Cencora, Inc. continues to build on its legacy as a trusted healthcare solutions provider, leveraging its expertise and resources to drive growth and innovation in the industry. For more information, please visit the company's website at https://www.cencora.com, or refer to its ISIN: US03073E1055, which is classified as a common stock under the GICS Sub Industry: Health Care Distributors.